• Home
  • Search Results

Search Results

2527 studies match your search
Open

AWARD Peds Plus

This study is being done to see how safe a study drug is and how well it will work to help people with type 2 diabetes mellitus (T2DM). We have asked you to join this study because you have T2DM. During this study, participants will come to the clinic and receive treatment for their T2DM. All patients will get study drug. During the study, the dosage of the study drug is increased to test the safety and effectiveness from higher doses.

Age & Gender
  • 10 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Diabetes
  • Obesity
Open

Gait and Cartilage Strain Study

Ever wonder how the way you walk may affect your knees? Have you ever had an ACL reconstruction? You may be able to take part in a study to learn more about how different types of force applied to your legs can affect your knee while walking on a treadmill.

Age & Gender
  • 16 years ~ 35 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Minority Health
  • Physical Disability
  • and 9 more
Coming Soon

Study of NXC-201 CAR-T in Patients with Light Chain (AL) Amyloidosis

The purpose of this research is to test the safety of NXC-201 (a CAR-T cell targeting the BCMA protein) at different doses in participants with relapsed/refractory AL amyloidosis, and to confirm the best dose for further testing. In addition, the study will evaluate the effectiveness of NXC-201 in treating relapsed/refractory AL amyloidosis

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers)
Not currently enrolling

Age-Altered Functional Brain Network Study

The main purpose of this study is to explore how aging affects not only the local organization of hippocampus but also the corresponding global connectivity. Additionally, the findings of age-dependent alteration on hippocampal subfield networks lay the foundation for the development of an early biomarker of Alzheimer's disease.

Age & Gender
  • 18 years ~ 85 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Coming Soon

Epcoritamab in Previously Treated WM

The purpose of this study is to determine if epcoritamab can be used to treat patients with previously treated WM.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Lymphoma)
Open

Geriatric Functional Assessment System: A Clinician's Perspective

The goal of this interview is to gather a clinician's perspective on the feasibility and potential integration of a new Geriatric Functional Assessment System (GFAS) into their clinical practice. This proposed system is a clinic-based wearable device designed to collect visual and motion data from older adults during their primary care visits that will help assess physical function. Its goal is to collect and process data, apply machine learning, and enable clinicians to identify early signs of functional decline.

Age & Gender
  • 22 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Injury/Injury Prevention
  • Opinions and Perceptions
  • UNC or UNC Health employees
Visit Location
100% Remote (online, phone, text)
Open

ARGX-117-2302- Phase 3, Randomized, Double-Blind study to evaluate effectiveness and safety of empasiprubart versus IVIg in patients with multifocal motor neuropathy

This study aims to evaluate the effectand safety of empasiprubart compared with intravenous immunoglobulin (IVIg) treatment in adults with multifocal motor neuropathy (MMN). This study will also check how empasiprubart affects the body, how it is absorbed and removed from the body, and how the immune system reacts to empasiprubart.

Age & Gender
  • 18 years ~ 99 years
  • Male, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
Open

Alcohol Labeling Study

Are you 21+ and regularly drink alcohol? You may be eligible for a study to help us learn what people think about alcohol. Participants who complete the study can earn up to $275 in virtual gift cards.

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Visit Location
Open

Resistant Hypertension Study

Do you have high blood pressure even though you are taking 3 or 4 different medications to treat it? You might be able to participate in a study to find out if you also have high cortisol levels.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Pressure
Coming Soon

Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/​Metastatic Head and Neck Squamous Cell Carcinoma

The purpose of this study is to test the effectiveness and safety of the combination of an investigational vaccine, PDS0101, and the standard of care, compared to the standard of care treatment alone.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research